Mineralys Therapeutics Inc
MLYS
NASDAQ
Biotechnology
$25.64
USD
-0.45 (-1.72%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.31B
Volume 697.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
NRIX | Nurix Therapeutics Inc | $2.69B | - | -58.4% | - | |
RARE | Ultragenyx Pharmaceutical Inc | $2.65B | - | +17.5% | - | |
BCRX | BioCryst Pharmaceuticals Inc | $2.52B | - | +68.7% | - | |
KLRA | Kailera Therapeutics Inc | $2.46B | - | - | - | |
CDNA | CareDx Inc | $2.45B | 22.05 | +34.4% | - | |
MLYS | Mineralys Therapeutics Inc | $2.41B | - | - | - | |
PGEN | Precigen Inc | $2.33B | - | +1875.0% | - | |
COAG | Hemab Therapeutics Holdings Inc | $2.33B | - | - | - | |
SION | Sionna Therapeutics Inc | $2.31B | - | - | - | |
VERA | Vera Therapeutics, Inc | $2.27B | - | - | - | |
VCEL | Vericel Corp | $2.27B | 93.85 | +22.9% | - | |
PVLA | Palvella Therapeutics Inc | $2.19B | - | -97.2% | - |
Top Peer by Growth
Precigen Inc
+1875.0% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
CareDx Inc
+290.6% Return